Provided By GlobeNewswire
Last update: May 7, 2025
-- First Quarter 2025 Performance Reflects Contribution from Multiple Revenue Streams Across Geographies, Efforts to Support Strong Balance Sheet and Continued Strategic Execution to Maximize Global Value of VASCEPA®/VAZKEPA® --
Read more at globenewswire.comNASDAQ:AMRN (7/22/2025, 1:36:47 PM)
15.37
-0.18 (-1.16%)
Find more stocks in the Stock Screener